AI in Oncology Paris

2026-06-22 09:00 2026-06-23 17:30 AI in Oncology Paris

Following the success of the first edition, which brought together over 400 participants in Paris in June 2025, we are delighted to announce the return of the AI in Oncology Conference by IHU PRISM, taking place on June 22–23, 2026, at the Novotel Paris Tour Eiffel: An international conference dedicated to advancing the application of artificial intelligence in cancer care and research.
The 2025 edition enabled participants to delve into key aspects of AI in Oncology including radiology, digital pathology, generative models, multiomics and precision oncology trials.
In 2026, we will build on this momentum by broadening our scope to include the latest developments and real-world applications of AI that are transforming oncology today.
Beyond the scientific content, AI in Oncology Conference by IHU PRISM will once again serve as a unique platform to exchange ideas, share experiences, and foster collaborations among clinicians, researchers, data scientists, and industry experts shaping the future of personalized cancer care.
We look forward to welcoming you again in Paris for this second edition of AI in Oncology Conference by IHU PRISM, and to continuing together the exciting journey at the intersection of AI and oncology.

Novotel tour eiffel
Thematic : Research

In 2026, we will build on the last edition by broadening our scope to include the latest developments and real-world applications of AI that are transforming oncology today.

  • Public
    Réservé à certains publics
  • Event type
    Conférence / séminaire / webinaire
  • Conditions

    payant, sur inscription

  • Dates
    22 and 23 June
    09:00 am - 05:30 pm
  • Location
    Novotel tour eiffel

Following the success of the first edition, which brought together over 400 participants in Paris in June 2025, we are delighted to announce the return of the AI in Oncology Conference by IHU PRISM, taking place on June 22–23, 2026, at the Novotel Paris Tour Eiffel: An international conference dedicated to advancing the application of artificial intelligence in cancer care and research.
The 2025 edition enabled participants to delve into key aspects of AI in Oncology including radiology, digital pathology, generative models, multiomics and precision oncology trials.
In 2026, we will build on this momentum by broadening our scope to include the latest developments and real-world applications of AI that are transforming oncology today.
Beyond the scientific content, AI in Oncology Conference by IHU PRISM will once again serve as a unique platform to exchange ideas, share experiences, and foster collaborations among clinicians, researchers, data scientists, and industry experts shaping the future of personalized cancer care.
We look forward to welcoming you again in Paris for this second edition of AI in Oncology Conference by IHU PRISM, and to continuing together the exciting journey at the intersection of AI and oncology.